George brings over 30 years of medical leadership experience to Summit Diagnostics. In 2007 he founded Summit Diagnostics to help clients understand the growing drug testing market. He established standards that led the way and helped reduce costs in point of care and laboratory testing.
George was the first to add Buprenorphine to the first testing platforms, which helped physicians recognize the need for patient monitoring in an effort to increase safety and patient safety and success.
In 2008 George helped research and launch the first Pharmacogenomics testing partnerships that helped medical professionals understand the benefit of this testing.
George Co publishes “Recovery Plus Magazine” the first international publication that addresses addiction and recovery.